Abstract
Nowadays there is no treatment option except antioxidant support which decelerates the progression of dry-type age-related macular degeneration (ARMD) which is one of the most common reasons for legal blindness in elderly people. Promising outcomes have been obtained with stem cell treatment and gene therapy in dry-type ARMD in the recent studies which are done in the light of the advanced bioengineering developments. In addition, very rapid advances have been developing related to the retinal prosthesis implantation which is performed to regain their functional vision in end-stage ARMD patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
